Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
about
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cellsOsteoprotegerin in bone metastases: mathematical solution to the puzzleTumor-expressed adrenomedullin accelerates breast cancer bone metastasis.Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat modelTargeting the osteosarcoma cancer stem cellThe role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.Breast cancer at bone metastatic sites: recent discoveries and treatment targets.Photodynamic therapy in spinal metastases: a qualitative analysis of published results.Physiopathology of spine metastasis.Vitamin D and breast cancer.The role of the bone microenvironment in skeletal metastasis.Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro.A "class action" against the microenvironment: do cancer cells cooperate in metastasis?Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cellsSerum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers.Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways.Mast cell: insight into remodeling a tumor microenvironment.Animal model for mammary tumor growth in the bone microenvironment.Concomitant resistance and early-breast cancer: should we change treatment strategies?Matrix metalloproteinase-based photodynamic molecular beacons for targeted destruction of bone metastases in vivo.Beyond radiation therapy: photodynamic therapy maintains structural integrity of irradiated healthy and metastatically involved vertebrae in a pre-clinical in vivo model.The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis.TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis.Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.Regulation of breast cancer induced bone disease by cancer-specific IKKβ.Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12.Therapeutic and Preventive Effects of Osteoclastogenesis Inhibitory Factor on Osteolysis, Proliferation of Mammary Tumor Cell and Induction of Cancer Stem Cells in the Bone Microenvironment.
P2860
Q26861403-55E64147-7670-49D5-9924-CD671CBE8A7BQ27329714-A8C2FB84-AB84-4CA7-85A7-25FA2713C8D0Q30301242-6F190B99-6D65-4F06-91FF-7B61A29EF2E1Q33750865-6C2F0DEF-3ED9-40B8-9776-0419C21DAC0AQ34335524-EF081C1D-D89B-4B1D-98F1-5D7B6A2955D3Q34365807-2D4D0498-80A8-4631-BE74-87F7C7D45110Q34485079-6D124B30-0F56-489C-964B-7E743210BF87Q34684910-57CA88B1-6067-4A76-B3D3-11E8A944DB52Q34939979-7F64C948-C4E0-4931-8F6E-9BF635870AC9Q35602144-32FEF789-C6B0-4C1D-959D-F705468F4933Q35692236-DB0F8483-E8D8-4531-8246-83F0D43A9416Q35705253-AF7FABDB-0EF6-43A9-A97E-17045650F4EAQ36491430-3EA55E88-505A-4D08-B168-DE97ECB99B4AQ36571484-AE936887-B851-4C04-882D-07D17318E22EQ36649455-03D28C65-5802-4611-B103-9C13FB96258AQ36861448-F4BB51A0-AEEF-497F-BE44-3FC2415F7314Q37218904-5609A19E-66F3-4FD9-9E6E-BB414E2223D4Q37315780-33CE1E80-7D62-4CB3-B8BD-F11B8D49FDF7Q37446271-D2C9BE39-32CA-481B-8F5F-32240FE75B7FQ37832440-C12493E8-EBC2-4694-ADF2-047AF2B04995Q38075495-510E5878-9F19-434C-BB09-6852F62846BFQ38171964-2E72BD40-23FB-4A0C-B2C4-0A042208E2ADQ39176626-5EBC4767-21B0-4707-AB06-F2B62C901895Q39315403-5CE425EB-A1BF-4330-B7ED-0AAB5B6AC83AQ45741600-FCA518F0-7E14-4703-8D47-404841B27C02Q48293049-767A5E8E-68A3-47DB-B867-559B03E70726Q49891124-C514D5DC-6DA6-471B-9F68-757AF0BD947BQ52584355-1E05795B-1535-4C4D-AFA8-C1EC7EB76B43Q53052529-AA0950C3-FB50-474C-9FD5-8C5F2CE7BC9AQ55117611-8A33F51E-8765-4A7C-9BC5-2C0D9EEF2075
P2860
Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular interactions between ...... ent drive skeletal metastases.
@ast
Molecular interactions between ...... ent drive skeletal metastases.
@en
type
label
Molecular interactions between ...... ent drive skeletal metastases.
@ast
Molecular interactions between ...... ent drive skeletal metastases.
@en
prefLabel
Molecular interactions between ...... ent drive skeletal metastases.
@ast
Molecular interactions between ...... ent drive skeletal metastases.
@en
P2093
P2860
P1476
Molecular interactions between ...... ent drive skeletal metastases.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10555-006-9023-1
P577
2006-12-01T00:00:00Z
P6179
1047474992